Manulife (Manufacturers Life Insurance)’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Hold	0	–	–	–	4478
2017 Q1	–	Hold	0	–	–	–	4425
2016 Q4	–	Hold	0	–	–	–	4481
2016 Q3	–	Hold	0	–	–	–	4376
2016 Q2	–	Hold	0	–	–	–	4358
2016 Q1	–	Hold	0	–	–	–	4181
2015 Q4	–	Hold	0	–	–	–	4086
2015 Q3	–	Hold	0	–	–	–	4124
2015 Q2	–	Hold	0	–	–	–	4133
2015 Q1	–	Hold	0	–	–	–	4051
2014 Q4	–	Hold	0	–	–	–	4062
2014 Q3	–	Hold	0	–	–	–	3989
2014 Q2	–	Sell	-21	Closed	-$79K	–	3797
2014 Q1	$84	Buy	21 +1	+5%	+$4.46K	﹤0.01%	3120
2013 Q4	$73	Buy	20 +1	+5%	+$3.79K	﹤0.01%	3151
2013 Q3	$75	Sell	19 -1	-5%	-$7.5K	﹤0.01%	3091
2013 Q2	$202K	Buy	+20	New	+$222K	﹤0.01%	2553

Other funds holding FRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s FRTX Position: Q2 2017 in Review

Manulife (Manufacturers Life Insurance) held its Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) position steady in Q2 2017 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4478.

Manulife (Manufacturers Life Insurance) first reported a position in FRTX in Q2 2013 and has held it in 4 quarters since. The position peaked at $202K in Q2 2013. 28 funds tracked by Wall St. Rank hold FRTX as of Q2 2017.

Manulife (Manufacturers Life Insurance) held 0 shares of Fresh Tracks Therapeutics, Inc. Common Stock worth $0 as of Q2 2017.
Manulife (Manufacturers Life Insurance) left its Fresh Tracks Therapeutics, Inc. Common Stock share count unchanged in Q2 2017.
Fresh Tracks Therapeutics, Inc. Common Stock made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2017, its #4478 holding.
Manulife (Manufacturers Life Insurance) first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and has held it in 4 quarters since.
Manulife (Manufacturers Life Insurance)'s Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $202K in Q2 2013.
28 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q2 2017.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2017, filed 15 Aug 2017.